Glaxosmithkline Pharmaceuticals Ltd.
Share Price Target & Analysis
NSE:GLAXO
VWAP
Open
Close
High
Low
52 Week High
-29.60 (-1%)
GLAXO
(PHARMA)Trending & Favourite
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: GLAXO Share Price Financial Analysis & Valuation
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Mid Cap company with Market Capitalization of Rs 27996 (in Cr). Total number of free float shares are 16.9 (in Lacs).
Glaxosmithkline Pharmaceuticals Ltd. is listed on NSE with Exchange ID - INE159A01016 and trading code is NSE:GLAXO with short name GlaxoSmithKline.
In the past 1 year, Glaxosmithkline Pharmaceuticals Ltd. has declared an equity dividend of Rs 1.95 per share. At the current share price of GLAXO at Rs 2928.20, this results in a dividend yield of 0.07 %.
As per the Fundamental Analysis of NSE:GLAXO, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine GLAXO underlying value and future prospects. All of this data is available in GLAXO financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:GLAXO, it is clearly understood that GLAXO is Economical performer in terms of earnings and profit margins with an EPS of 63.65. NSE:GLAXO book value per share as of today is 147.25. The current price to book ratio for GLAXO as of Sep 08, 2026 is 19.89.
Valuation of the Stock: The current valuation of GLAXO stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of GLAXO whether to BUY this stock at current valuation. The delivery percentage of GLAXO is 72707% is very crucial parameter which shows that 72707% investors are anticipating that the price of GLAXO share should go up with VWAP at 2961.25.
Now, the main question is whether to BUY or SELL, NSE:GLAXO at current valuation.
As per latest Analysis No. #1540:-
⇑ STRONG BUY GLAXO if All Greens
⇗ BUY GLAXO (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD GLAXO (With Stop Loss) if only 1 Green
⇘ SELL GLAXO if NO Green Indicator
NSE: GLAXO Share Price Today (Sep 08, 2026)
(Glaxosmithkline Pharmaceuticals Ltd. Daily Analysis on the basis of GLAXO Intraday Graph & Trend)
Glaxosmithkline Pharmaceuticals Ltd. share price moved Down by -1% from its previous close of Rs 2957.8. GLAXO stock last traded price is 2928.20. GLAXO share price trend is Down with a total of 50684 stocks traded till now. It has touched an intraday high of Rs 3001.3 and an intraday low of Rs 2921.2. The GLAXO trading at 2928.20, Down by Rs. -29.60, or -1 percent which suggests that most of the Traders are anticipating that the price of GLAXO share should go Down.
NSE: GLAXO Share Price Tomorrow Prediction
(Glaxosmithkline Pharmaceuticals Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of GLAXO)
Glaxosmithkline Pharmaceuticals Ltd. share price moved Down by -1%. GLAXO share price short term trend is Down. It suggests that GLAXO Share Price for Tomorrow remains the same with VWAP at 2961.25 will be treated as stop loss for intraday traders. Glaxosmithkline Pharmaceuticals Ltd. Long term investors can follow the GLAXO long term trend as mentiond in future forecast table.
NSE Code |
NSE: GLAXO |
GLAXO Share Price Today |
2928.20 |
GLAXO Share Price Target Prediction for 2026 ^ |
2502.6 - 3136.1 |
GLAXO Share Price Target Prediction for 2027*^ |
3136.1 - 3341 |
GLAXO Share Price Target Prediction for 2028*^ |
3341 - 3574.9 |
GLAXO Share Price Target Prediction for 2029*^ |
3754 |
GLAXO Share Price Target Prediction for 2030*^ |
3861 |
GLAXO Share Price Target Prediction for 2035*^ |
4208 |
| GLAXO Current Book Value |
146.5 |
*Glaxosmithkline Pharmaceuticals Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^GLAXO share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
GLAXO Technical Analysis
Candlestick Pattern: @2996.1| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 3051.22 | SELL | 3024.88 | SELL |
| MA_12 | 2950.35 | BUY | 2943.62 | BUY |
| MA_20 | 2829.72 | BUY | 2872.23 | BUY |
| MA_32 | 2720.38 | BUY | 2764.13 | BUY |
| MA_50 | 2623.15 | BUY | 2682.24 | BUY |
| MA_100 | 2482.8 | BUY | 2583.7 | BUY |
| MA_200 | 2474.83 | BUY | 2542.78 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 2829.72 | Uptrend |
| MACD | 10.81 | BUY |
| ADX | 42.25 | Strong Trend |
| DMI (+/-) | 33.3 / 16.88 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 64.99 | Neutral |
| STOCHASTIC_K (Fast) | 32.05 | Neutral |
| STOCHASTIC_D (Slow) | 65.72 | Neutral |
| CCI | 44.39 | Neutral |
| PSAR | 2908.9 | BUY |
| TRUE RANGE | 83.7 | Neutral |
| ATR | 85.83 | Neutral |
| WILLIAMS R | -24.23 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 0 | Oversold |
| STOCHASTIC RSI D | 33.33 | Neutral |
| MOMENTUM | 333.8 | BUY |
| Duration | Value |
|---|---|
| 1 Year | 7.41% |
| 3 Months | 35.91% |
| 1 Month | 12.54% |
| 1 Week | 1.1% |
| Action | Overall (%) |
|---|---|
| BUY | 60% |
| NEUTRAL / HOLD | 30% |
| SELL | 10% |
Most popular Questions & Answers about GLAXO (/ FAQ GLAXO)
Glaxosmithkline Pharmaceuticals Ltd. stock last traded price is 2928.20. GLAXO share price moved Down by -1% from its previous close of Rs 2957.8.
Glaxosmithkline Pharmaceuticals Ltd. share price trend is Down with a total of 50684 stocks traded till now. It has touched an intraday high of Rs 3151.907 and an intraday low of Rs 2921.2. The GLAXO trading at 2928.20, Down by Rs. -29.60, or -1 percent which suggests that most of the Traders are anticipating that the price of GLAXO share should go Down and the Stop Loss will be around 2961.25.
The market cap of Glaxosmithkline Pharmaceuticals Ltd. is ₹27996 (in Cr) as of Sep 07, 2026.
The current price to earning ratio for Glaxosmithkline Pharmaceuticals Ltd. as of Sep 07, 2026 is 46.78.
The current price to book ratio for Glaxosmithkline Pharmaceuticals Ltd. as of Sep 07, 2026 is 19.89.
The highest price of Glaxosmithkline Pharmaceuticals Ltd. stock is ₹3120.7 in the last 52-week.
The lowest price of Glaxosmithkline Pharmaceuticals Ltd. stock is ₹2088.1 in the last 52-week.
Glaxosmithkline Pharmaceuticals Ltd. share trading at ₹2928.20, Down by Rs. -29.60, or -1 percent which suggests that most of the traders are anticipating that the price of GLAXO share should go Down.
In 2026, Stock price target for Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) will be around ₹2502.6 on downside and ₹3136.1 on upside. Glaxosmithkline Pharmaceuticals Ltd. share price target is based on current financial year earings of the company.
In 2027, Stock price target for Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) will be around ₹3136.1 on downside and ₹3341 on upside. Glaxosmithkline Pharmaceuticals Ltd. share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) will be around ₹3341 on downside and ₹3574.9 on upside. Glaxosmithkline Pharmaceuticals Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) will be around ₹3861 Glaxosmithkline Pharmaceuticals Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of GLAXO.
The price of Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) shares moved by -1%. The short-term trend for GLAXO share price is Down. It implies that the share price of GLAXO will stay the same tomorrow and that intraday traders should treat VWAP at 2961.25 as a stop loss. Investors with a long-term outlook can track GLAXO long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of GLAXO stock is 763.2. Compared to the current market price of 2928.20 INR, the GLAXO stock is Overvalued by 73.9%.
As per the fundamental analysis of Glaxosmithkline Pharmaceuticals Ltd. (GLAXO), it is of Economical quality in terms of earnings and profit margins with an EPS of 63.65. Glaxosmithkline Pharmaceuticals Ltd. book value per share as of today is 147.25. The current price to book ratio for GLAXO as of Sep 08, 2026 is 19.89.
NSE:GLAXO News & Other Useful Information about GLAXO Share Price
Peer Comparison of NSE: GLAXO
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1885.90 | 16.35 | 97.89 |
| DIVISLAB | 9575.00 | 115.55 | 663.06 |
| MEDICAMEQ | 285.75 | 12.15 | 208.08 |
| CIPLA | 1384.00 | 51.67 | 434.03 |
| DRREDDY | 1151.00 | 53.19 | 380.63 |
| TORNTPHARM | 4960.00 | 87.32 | 235.7 |
| BIOCON | 392.30 | 1.27 | 166.51 |
| LUPIN | 2104.70 | 154.86 | 718.37 |
| ALKEM | 5181.00 | 212.33 | 1218.48 |
| AUROPHARMA | 1692.00 | 46.49 | 403.84 |
| ABBOTINDIA | 25555.00 | 766.11 | 2448.41 |
| GLAXO | 2928.20 | 63.65 | 147.25 |
| IPCALAB | 1967.20 | 56.72 | 329.23 |
| LAURUSLABS | 1946.90 | 20.74 | 102.57 |
| LALPATHLAB | 1912.50 | 39.68 | 157.23 |
| PFIZER | 4310.70 | 170.54 | 963.41 |
| AJANTPHARM | 3579.30 | 89.3 | 363.23 |
| SANOFI | 3114.90 | 158.05 | 332.96 |
| NATCOPHARM | 825.75 | 82.14 | 481.67 |
| APLLTD | 808.50 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2474.50 | 1.24 | 881.78 |
| AAREYDRUGS | 98.03 | 2.39 | 53.38 |
| JUBLPHARMA | 997.75 | 4.35 | 145.63 |
| SPARC | 203.27 | 48.14 | 40.45 |
| GRANULES | 895.35 | 23.25 | 180.42 |
| ASTRAZEN | 6875.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2770.10 | 55.52 | 285.6 |
| FDC | 345.95 | 21.19 | 161.21 |
| HIKAL | 247.00 | 9.34 | 96.63 |